Follow Us on StockTwits

Hearing Takeover Rumors Circulating About OpGen

Posted by on December 26, 2016 7:51 AM
Tags: , , , , , , , , ,
Categories: Stocks

December 26, 2016: Hearing takeover rumors circulating about OpGen. The rumors are coming from the fact that Merck Global Health Innovation Fund disclosed a huge 37.5% stake in OpGen according to a schedule 13D filing.

November 16, 2016: Rodman & Renshaw/H.C. Wainwright reiterates a Buy rating on OpGen but cuts their price target from $3.25 to $2.50.

November 14, 2016: OpGen collaborates with Merck to develop novel rapid diagnostics and informatics tools to combat antibiotic resistance.

OpGen Stock Chart

OpGen, Inc. is an early commercial-stage company using molecular testing and bioinformatics to assist healthcare providers in combating multi-drug resistant bacterial infections.

Follow me

Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on unless specifically stated in the article. Owner of Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.
Follow me